AnHeart Therapeutics

Series-B+
anhearttherapeutics.com Biotech & Healthcare Hangzhou, China Founded 2019 51-100
Total Funding $81M
Latest Round $61M Series-B+
Last Announced Dec 14, 2021
Investors 7 Backers
Decision Makers 6 Verified

About AnHeart Therapeutics

AnHeart Therapeutics is a developer of innovative pharmaceutical products.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Hangzhou, China
Year Founded 2019
Team Size 51-100
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website anhearttherapeutics.com
Domain Registered Date Nov 14, 2018

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $61,000,000 · Series-B+

    startupintros.com

  2. Capital Raise

    Raised $20,000,000 · Series-A

    startupintros.com

  3. Milestone

    Company founded

    Hangzhou, China

  4. Milestone

    Website domain registered

    anhearttherapeutics.com

Investors & Backers

7
Cenova
Decheng Capital
Innovent Biologics
Laurion Capital Management
Octagon Capital Advisors
Sage Partners
Vertex Ventures China

Funding History

2 Rounds
Series-B+ · Dec 14, 2021
Series-A · Aug 10, 2020

Founders & Leadership

6

Charlotte Arnold

Chief Corporate Affairs Officer

Work email & phone locked Unlock →

Edward Lang Jr

Chief Business Officer

Work email & phone locked Unlock →

Hua Zheng

SVP, Head of Global Regulatory Affairs

Work email & phone locked Unlock →

Junyuan (Jerry) Wang

Founder

Work email & phone locked Unlock →

Lihua Zheng

Founder

Work email & phone locked Unlock →

Shuanglian (Lian) Li

SVP and Chief Medical Officer (US)

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts